AptarGroup found using ticker (ATR) now have 7 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 135 and 105 calculating the average target price we see 117.43. Now with the previous closing price of 107.65 this indicates there is a potential upside of 9.1%. The 50 day moving average now sits at 101.87 while the 200 day moving average is 106.17. The company has a market capitalisation of $7,014m. Company Website: https://www.aptar.com
The potential market cap would be $7,651m based on the market concensus.
You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.
AptarGroup provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.